Kevin D. Read
Impact in
-
- Research on Leishmaniasis Studies
- Epidemiology top 2%
- Trypanosoma species research and implications
Papers in
- Epidemiology 33
- Trypanosoma species research and implications 33
-
- Research on Leishmaniasis Studies 25
- Co-authors
- Alan H. Fairlamb (15 shared papers)Ian H. Gilbert (26 shared papers)Susan Wyllie (11 shared papers)Paul G. Wyatt (19 shared papers)Suzanne Norval (15 shared papers)Manu De Rycker (10 shared papers)David Horn (7 shared papers)Laste Stojanovski (14 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)ChemMedChem (6 papers)Nature Reviews Microbiology (5 papers)Nature Communications (3 papers)Drug Metabolism and Disposition (3 papers)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Kevin D. Read
76 papers receiving 2.9k citations
Kevin D. Read's Hit Papers
Peers
Comparison fields: 5 of 118
- Public Health, Environmental and Occupational Health 1.0k
- Epidemiology 1.1k
- Organic Chemistry 816
- Parasitology 166
- Toxicology 85
Countries citing papers authored by Kevin D. Read
This map shows the geographic impact of Kevin D. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Read more than expected).
Fields of papers citing papers by Kevin D. Read
This network shows the impact of papers produced by Kevin D. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Read. The network helps show where Kevin D. Read may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin D. Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need Hit paper breakdown → | 2017 | 306 |
| 2 | 2007 | 225 | |
| 3 | 2016 | 178 | |
| 4 | 2017 | 123 | |
| 5 | 2012 | 123 | |
| 6 | 2010 | 101 | |
| 7 | 2022 | 99 | |
| 8 | 2011 | 93 | |
| 9 | 2009 | 80 | |
| 10 | 2011 | 77 | |
| 11 | 2016 | 69 | |
| 12 | 2016 | 67 | |
| 13 | 2016 | 61 | |
| 14 | 2010 | 56 | |
| 15 | 2013 | 53 | |
| 16 | 2008 | 51 | |
| 17 | 2010 | 51 | |
| 18 | 2020 | 50 | |
| 19 | 2010 | 48 | |
| 20 | 2010 | 47 |
About Kevin D. Read
Kevin D. Read is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health, Molecular Biology, Organic Chemistry and Oncology, having authored 78 papers that have together received 3.0k indexed citations. Recurring topics across this work include Trypanosoma species research and implications (33 papers), Research on Leishmaniasis Studies (25 papers), Synthesis and Biological Evaluation (16 papers), Computational Drug Discovery Methods (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Biochemical and Molecular Research (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (1.0k citations), Epidemiology (1.1k citations), Organic Chemistry (816 citations), Parasitology (166 citations) and Toxicology (85 citations). Kevin D. Read has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Alan H. Fairlamb, Ian H. Gilbert, Susan Wyllie, Paul G. Wyatt, Suzanne Norval, Manu De Rycker, David Horn, Laste Stojanovski, Stephen Patterson and Leah S. Torrie. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Nature Reviews Microbiology, Nature Communications and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.